Anica Law, MD, MS

Assistant Professor, Medicine

Anica Law
617.358.2800
72 East Concord Street

Biography

Dr. Law is a Pulmonary and Critical Care physician, clinical epidemiologist, and health services researcher with a focus on understanding determinants of outcomes after critical illness. An unprecedented number of patients now survive the intensive care unit (ICU) but suffer severe organ dysfunction, requiring forms of long-term organ support, such as mechanical ventilation or artificial nutrition. Using both granular clinical and national claims databases, and leveraging natural experiments where feasible (e.g., policy changes), the goal of her research is to better inform decision-making during critical illness and the optimal delivery of care after acute critical illness.

Dr. Law serves as Deputy Editor at CHEST Critical Care. Within the American Thoracic Society, she is Chair of the Critical Care Assembly’s Planning Committee.

Websites

Education

  • University of Pennsylvania School of Medicine, MD
  • Harvard School of Public Health, MS
  • Harvard College, AB

Publications

  • Published on 3/1/2024

    Bosch NA, Vail EA, Law AC, Homer-Bouthiette C, Walkey AJ, Moitra VK. Practice Patterns and Outcomes of Potassium Repletion Thresholds during Critical Illness. Ann Am Thorac Soc. 2024 Mar; 21(3):456-463. PMID: 38134433.

    Read at: PubMed
  • Published on 1/25/2024

    Teja B, Berube M, Pereira TV, Law AC, Schanock C, Pang B, Wunsch H, Walkey AJ, Bosch NA. Effectiveness of Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Am J Respir Crit Care Med. 2024 Jan 25. PMID: 38271488.

    Read at: PubMed
  • Published on 1/19/2024

    Kearney CM, Sangani R, Shankar D, O'Connor GT, Law AC, Walkey AJ, Bosch NA. Comparative Effectiveness of Mepolizumab, Benralizumab and Dupilumab among Patients with Difficult-to-Control Asthma. Ann Am Thorac Soc. 2024 Jan 19. PMID: 38241013.

    Read at: PubMed
  • Published on 1/1/2024

    Qadir N, Sahetya S, Munshi L, Summers C, Abrams D, Beitler J, Bellani G, Brower RG, Burry L, Chen JT, Hodgson C, Hough CL, Lamontagne F, Law A, Papazian L, Pham T, Rubin E, Siuba M, Telias I, Patolia S, Chaudhuri D, Walkey A, Rochwerg B, Fan E. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024 Jan 01; 209(1):24-36. PMID: 38032683.

    Read at: PubMed
  • Published on 1/1/2024

    Shankar DA, Hawkins F, Alysandratos KD, Wilson KC, Walkey AJ, Bosch NA, Law AC. Uptake of Antifibrotics for Patients with Idiopathic Pulmonary Fibrosis: 2016-2022. Ann Am Thorac Soc. 2024 Jan; 21(1):170-173. PMID: 37879035.

    Read at: PubMed
  • Published on 12/1/2023

    Dinh J, Hinkle CF, Law AC, Walkey AJ, Bosch NA. Effect of Respiratory Viral Panel Adoption on Antibiotic Use in Ventilated Patients. Ann Am Thorac Soc. 2023 Dec; 20(12):1777-1783. PMID: 37748086.

    Read at: PubMed
  • Published on 11/1/2023

    Law AC, Bosch NA, Song Y, Tale A, Yeh RW, Kahn JM, Stevens JP, Walkey AJ. Patient Outcomes After Long-Term Acute Care Hospital Closures. JAMA Netw Open. 2023 Nov 01; 6(11):e2344377. PMID: 37988077.

    Read at: PubMed
  • Published on 11/1/2023

    Vail EA, Bosch NA, Law AC, Gershengorn HB, Wunsch H, Walkey AJ. Adoption of a Novel Vasopressor Agent in Critically Ill Adults. Ann Am Thorac Soc. 2023 Nov; 20(11):1662-1667. PMID: 37590119.

    Read at: PubMed
  • Published on 10/1/2023

    Bosch NA, Law AC, Walkey AJ. Immortal Time Bias Possibly Affecting Fludrocortisone-Hydrocortisone Findings-Reply. JAMA Intern Med. 2023 Oct 01; 183(10):1178-1179. PMID: 37669033.

    Read at: PubMed
  • Published on 8/22/2023

    Bosch NA, Law AC, Walkey AJ. Understanding the Facets of Emulating Randomized Clinical Trials. JAMA. 2023 Aug 22; 330(8):770. PMID: 37606680.

    Read at: PubMed

View 46 more publications: View full profile at BUMC

View all profiles